Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Alphamab Co Ltd (9966 HK)
Watchlist
Contact IR
118
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Henlius Biotech
•
07 Jan 2025 15:02
Henlius (2696 HK): Anxiety Creeping Back Ahead of the 22 January Vote
Several readers have enquired about my thoughts on the widening spread. Our conversations have raised several potential concerns that could explain...
Arun George
Follow
631 Views
Share
bullish
•
Horizon Robotics
•
07 Jan 2025 00:06
HSCI Index Rebalance Preview and Stock Connect: Updated Potential Changes in March 2025
There could be 89 changes for the HSCI in March. That could result in 73 changes to the Southbound Stock Connect list and also have implications...
Brian Freitas
Follow
1.5k Views
Share
bullish
•
Shanghai Henlius Biotech
•
22 Dec 2024 14:02
Henlius (2696 HK): Interesting Shareholder Movements with the Vote on 22 January
Key shareholders will be supportive, and this is a done deal. At the last close, the gross/annualised spread for a 15 February payment was 2.9%...
Arun George
Follow
602 Views
Share
bullish
•
Horizon Robotics
•
16 Dec 2024 21:10
HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March 2025
There could be 78 changes for the HSCI in March. That could result in 57 changes to the Southbound Stock Connect list and also have implications...
Brian Freitas
Follow
847 Views
Share
bullish
•
Quantitative Analysis
•
01 Dec 2024 02:07
Hong Kong Connect Flows (Nov 29th): Alibaba, Ping An Insurance, China Mobile, Meituan
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, Ping An Insurance, China Mobile, Meituan.
Ke Yan, CFA, FRM
Follow
560 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x